Researchers and authors can directly submit their manuscript online through this link Online Manuscript Submission.
SARS-CoV-2 mRNA Vaccines as Immunologic Adjuvants to Overcome Tumour Resistance to Immune Checkpoint Blockade
Citation
Sonu Kumar* and Khadga Raj Aran
Kumar, S., Aran, K. R. (2026). SARS-CoV-2 mRNA Vaccines as Immunologic Adjuvants to Overcome Tumour Resistance to Immune Checkpoint Blockade. J Traditional Medicine & Applications, 5(1), 01-13.

